Patents by Inventor Lilla Di Scala

Lilla Di Scala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predictive biomarker for cancer treatment with ADCC-enhanced antibodies
    Patent number: 9360481
    Abstract: The present invention is directed to methods for identifying which patients diagnosed with cancer will most benefit from treatment with an anti-cancer therapy comprising an ADCC-enhanced antibody.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: June 7, 2016
    Assignee: Roche Glycart AG
    Inventors: Lilla Di Scala, Stefan Evers, Christian Gerdes, Christoph Mancao, Alexandre Passioukov, Pablo Umana
  • Predictive biomarker for cancer treatment with ADCC-enhanced antibodies
    Publication number: 20140227256
    Abstract: The present invention is directed to methods for identifying which patients diagnosed with cancer will most benefit from treatment with an anti-cancer therapy comprising an ADCC-enhanced antibody.
    Type: Application
    Filed: January 21, 2014
    Publication date: August 14, 2014
    Applicant: ROCHE GLYCART AG
    Inventors: Lilla Di Scala, Stefan Evers, Christian Gerdes, Christoph Mancao, Alexandre Passioukov, Pablo Umana